Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02414919 · ClinicalTrials.gov registry record
Duration of Use of Highly Effective Reversible Contraception
A clinical trial, sponsored by Bayer.
- Completed
- Registry status
- 13,880
- Enrollment target
NCT02414919 is a clinical trial that has completed, run by Bayer. The registered enrollment target is 13,880 participants.
The verdict
NCT02414919 has completed, sponsored by Bayer.
- COMPLETED
- Registry status
- 13,880 participants
- Enrollment target
Study Summary
To assess the proportion of women who use HERC for ≥2 years of duration
Interventions
- DRUG ParaGard
- DRUG Mirena (Levonorgestrel IUS, BAY86-5028)
- DRUG Implanon/Nexplanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13,880 participants |
| Start Date | 2015-04-01 |
| Est. Completion | 2016-03-28 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02414919
The ClinicalTrials.gov registry entry for NCT02414919 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13,880 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bayer, which has 591 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which ParaGard is the first listed.
NCT02414919 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02414919 about?
NCT02414919 is a clinical study titled "Duration of Use of Highly Effective Reversible Contraception". To assess the proportion of women who use HERC for ≥2 years of duration
What is the current status of trial NCT02414919?
This trial is currently completed. The enrollment target is 13,880 participants. The study started on 2015-04-01. Estimated completion is 2016-03-28.
What interventions are being tested in trial NCT02414919?
The interventions under investigation include: ParaGard (DRUG), Mirena (Levonorgestrel IUS, BAY86-5028) (DRUG), Implanon/Nexplanon (DRUG).
Who is sponsoring clinical trial NCT02414919?
This trial is sponsored by Bayer, which has 591 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.